Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: The Biggest Danger Facing PTSC, Is Action Required? - SGE - Fatwollit

While I agree that a PR may not be issued (though I would think that such an event would require a release/filing based on SEC regs), I really don't think it would matter much. We'd probably figure it out pretty quick and not have to wait for a 10K/Q, because with good news, assuming it is good enough to overcome the flippers/traders, we'd run and not pull back nearly as much. Consistently higher plateaus. And, ultimately, we would draw the same conclusion. So no harm, no foul.

We'd also, I believe, see the beginning of a PR blitz that would actually have an affect.

JMHO,

SGE

Share
New Message
Please login to post a reply